The Alzheimer’s disease diagnostic professional market is witnessing significant growth due to the increasing prevalence of neurodegenerative disorders, rising aging populations, and growing awareness regarding early disease detection. Healthcare systems across the world are increasingly focusing on improving diagnostic accuracy and accelerating treatment intervention for patients...

Reliable Metabolic Biomarker Testing Market Data is foundational for effective public health policy and commercial strategy. This data includes high-volume metrics on the number of tests performed annually by region, the utilization rates of specific biomarker panels (e.g., lipid profile vs. advanced metabolomic panels), and the adoption rates of new POC technologies. Epidemiological data on...